Research brings hope for the future
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Search results
“All the promising research makes you feel like there is light at the end of that very dark tunnel after all.”
Biotechnology company ProQR has announced encouraging results from its early analysis of the phase 1/2 trial of QR-421a, an innovative approach to treating sight loss caused by mutations in a particular section of the USH2A gene.
Researchers who received funding from Retina UK have carried out experimental gene therapy that is reported to have led to ‘life changing improvements’ to sight for four children with inherited sight loss.
We provide funding for innovative, high quality research projects investigating the causes and potential treatments for all forms of inherited retinal disease.
We always aim to provide a high standard of service to our community. If you are unhappy with any of our services it is important that you let us know.
These are some of the most commonly asked questions about volunteering for our charity.
We are proud to work collaboratively with a number of corporate partners to enable our community to live fulfilled lives today as well as supporting the pharmaceutical industry in their mission to develop potential new treatments.
Our community support us in many different ways, from completing surveys, volunteering, raising awareness and fundraising.
Organising your own fundraising is great fun and a brilliant way to involve your friends, family and local community.
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.